FindTrial
Sign In

Comparision of low dose (200 mcg) versus high dose (400mcg) bronchodilator response in asthmatic children

Comparison of bronchodilator response to different doses of inhaled salbutamol in asthmatic children - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/04/065106
Enrollment
76
Registered
2024-04-02
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J459- Other and unspecified asthma

Interventions

Intervention1: low dose inhaled salbutamol: 200 mcg of inhaled salbutamol as a bronchodilator in PFT screening duration- 12 months Control Intervention1: high dose bronchodilator: 400 mcg of inhaled s

Sponsors

Department of Pediatrics
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: FEV1/FVC ratio lower than 90%

Exclusion criteria

Exclusion criteria: bronchodilators taken before PFT Children with underlying chronic disease

Design outcomes

Primary

MeasureTime frame
To compare improvement in FEV1 from baseline after inhalation of different doses (400mcg and 200 mcg) of salbutamolTimepoint: 12 months—

Secondary

MeasureTime frame
Proportions of children having more than 12% BDR in both the groups To assess improvement in PEF, FEF 25 to 75 in both groups To assess adverse effects in both groupsTimepoint: 12 months—

Countries

India

Contacts

Public ContactThanmayi B M

AIIMS, JODHPUR

goyal.drjagdish@gmail.com8475000270

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026